HAIC (GEMOX)

DRUG2 trials

Sponsors

Shandong Cancer Hospital and Institute, UNICANCER

Conditions

Hepatocellular CarcinomaIntrahepatic Cholangiocarcinoma

Phase 2

First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC

TerminatedNCT06370663

Shandong Cancer Hospital and InstituteIntrahepatic Cholangiocarcinoma

Start: 2024-04-01End: 2024-06-01Updated: 2025-06-25

Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma

RecruitingNCT06904170

UNICANCERHepatocellular Carcinoma

Start: 2025-11-14End: 2030-09-01Target: 196Updated: 2026-02-03